DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Auto-Injectors Market Insights, Opportunity Analysis, Market Shares and Forecast, 2016 - 2022" report to their offering.
The global auto-injectors market is anticipated to witness an impressive growth rate of approx. 18.7% during the forecasted period 2016-2022.
The auto-injectors market is majorly driven by the rising prevalence of food allergies and anaphylaxis. In Canada, around $2.5 million individuals get affected by food allergy in 2015. According to EAACI (European Academy of Allergy and Clinical Immunology), there has been a seven-fold increase within the hospital admissions related to anaphylaxis in Europe in last decade. The rising prevalence of food allergies and anaphylaxis has boosted the demand for epinephrine auto-injectors that are primarily used for anaphylaxis management.
Some of their initiatives include offering $0 Co-Pay Card with auto-injectors and providing free auto-injectors for use in schools. Such steps have significantly influenced the demand for auto-injectors among patients and hence drives the growth of the auto-injectors market. The other key factors that have attributed towards the growth of the global auto-injectors market include rising concerns for the hazards related with needle stick injuries and growing need for targeted and sustained drug delivery. However, high price of auto-injectors is expected to restraint the growth of the overall market.
Companies Mentioned:
- Antares Pharma Inc.
- Amedra Pharmaceuticals Llc
- Becton, Dickinson Co.
- Bespak
- Biogen Idec
- Changzhou Delfu Technology
- Dali Medical Devices
- Mylan N.V.
- Novartis International Ag
- Oval Medical Technologies
- Owen Mumford
-
Pfizer
Key Topics Covered:
1. Introduction
2. Market Overview
3. Market Determinants
4. Sector Analysis
5. Market Segmentation
6. Geographic Analysis
7. Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/m93k7d/global
